Tarbox Family Office’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Tarbox Family Office's ANGO Position: Q3 2020 in Review
Tarbox Family Office sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 147 shares — an estimated $1K sold.
Tarbox Family Office first reported a position in ANGO in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.
- Tarbox Family Office reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
- Tarbox Family Office sold 147 AngioDynamics shares in Q3 2020, an estimated $1K.
- Tarbox Family Office first reported a position in AngioDynamics in Q1 2020 and held it in 2 quarters.
- Tarbox Family Office's AngioDynamics position peaked at $2K in Q1 2020.
- 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.
Based on Tarbox Family Office's 13F filing for Q3 2020, filed 22 Oct 2020.